Advancing the Cardiovascular Care of the Oncology Patient (Virtual)
Join us virtually for Advancing the Cardiovascular Care of the Oncology Patient taking place Feb. 9 – 11. This interdisciplinary and interspecialty course is designed to provide clinicians and researchers with the tools needed to improve the cardiovascular (CV) health of cancer patients in your everyday practice.
Cancer remains the second leading cause of death in the United States, exceeded only by heart disease, with an estimated 1.9 million new cases in 2022. Cancer treatment can have a diverse array of long-term and late effects, including CV events such as heart failure, valvular disease, coronary artery disease, arrhythmia, peripheral arterial disease, and thromboembolic events. In this contemporary treatment era, cardiologists, oncologists, and the entire interprofessional team need to understand the different types of cancers and cancer therapies (e.g., cytotoxic chemotherapy, radiation therapy, transplantation, targeted and immune therapies) and their associated cardiovascular risks, to help mitigate the associated cardiovascular complications.
Register today to join leading experts and course chairs Ana Barac, MD, PhD, FACC and Bonnie Ky, MD, MSCE, FACC virtually on Feb. 9 – 11 as they share emerging strategies and best practices to manage the health of cancer patients. This educational experience is designed for you to stay on the leading edge of this rapidly evolving field!
Want to join us in person? Join us in Washington, DC to get all the education you need to stay at the leading edge of this rapidly evolving field!
The goal of this course is to equip the cardio-oncology community with practical scientific knowledge fostering the progression of patient-centered, evidence-based, collaborative cardiovascular and cancer care for patients living with and beyond cancer.
- Identify the oncologic indications, mechanisms of action, and cardiotoxicity risk of specific therapies that comprise the pillars of cancer treatment such as chemotherapy, immune therapy, targeted therapy, and radiation.
- Define the evidence supporting clinical, imaging, and biomarker-guideline recommendations regarding risk stratification and monitoring strategies in cancer patients treated with potentially cardiotoxic therapies, with a focus on practical applications.
- Apply evidence-based pharmacologic and non-pharmacologic strategies to mitigate and actively manage the short- and long-term cardiotoxicity risk in patients living with and beyond cancer.
- Recognize the mechanistic and epidemiologic overlap between cancer and cardiovascular disease, going beyond the cardiotoxicity of cancer therapies to understand their broader impact on health.
- Describe the impact of health disparities, genomic ancestry, and social determinants of health in cardiovascular disease in patients living with and beyond cancer.
- Evaluate the pathophysiologic basis of amyloidosis, as well as current diagnostic and treatment strategies.
- Design a multi-disciplinary, interprofessional cardio-oncology care team and successful framework to advance the overall cardiovascular care of cancer patients and survivors.
This educational activity is intended to address the educational needs for cardiologists, oncologists, internists, pharmacists, nurses, trainees and all members of the interprofessional care team who advance the clinical care of, and conduct clinical research that is relevant to, the growing population of cancer patients and survivors at risk for, or suffer from, cardiovascular disease.
Ana Barac, MD, PhD, FACC
Inova Health System
Bonnie Ky, MD, MSCE, FACC
University of Pennsylvania, Perelman School of Medicine
Course Vice Chair
Richard Cheng, MD, FACC
University of Washington
Alana Ferrari, PharmD
University of Virginia Medical Center
Teresa López-Fernández, MD
La Paz University Hospital
Vivek Narayan, MD, MS
Hospital of the University of Pennsylvania
Alexi Vasbender, PhD, RN
University of Michigan
Eric Yang, MD, FACC
University of California
Stephanie Dixon, MD, MPH
Nicolas Palaskas, MD, FACC
Ronald M. Witteles, MD
Join course chairs Ana Barac, MD, PhD, FACC and Bonnie Ky, MD, MSCE, FACC, and vice chair Richard Cheng, MD, FACC for an interactive pre-conference session on Friday, Feb. 9 from 2 – 5:30 p.m. This is a unique opportunity to connect with experts in the field to learn about the basics of cardio-oncology. The pre-conference workshop will focus on the topics of:
- Pharmacology 101
- How Do I Grow My Career in Cardio-Oncology? Educational Training, Financial Considerations, and Research and Publishing in Cardio-Oncology
- What I Wish I Knew Before (panel discussion)
- Online: Click the Register button at the top of the page
- Phone: 800-253-4636 or 202-375-6000
Registration for Advancing the Cardiovascular Care of the Oncology Patient includes access to the live stream and On Demand access to sessions through Feb. 19.
|Virtual Registration Rates||Early Bird
Until Oct. 31
Nov. 1 to Jan. 10
After Jan. 10
|Reduced (FIT, Emeritus, and CV Team members including nurses, PAs, pharmacists and other CV clinicians)||$225||$275||$325|
Cancellation, substitution, or transfer to another course is allowed if written notification is received four weeks before a scheduled course. A full refund minus a $250 processing fee will be given for written notifications received fewer than four weeks before the first day of the course. No refund will be given for no-shows.
ACC reserves the right to cancel the course in the unlikely event of insufficient enrollment or other unforeseen circumstances. If a course is canceled or postponed, ACC will refund registration tuition but cannot be held responsible for other costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies or hotels.
Thank you for your interest in submitting an abstract or case for 2024 Advancing the Cardiovascular Care of the Oncology Patient.
The submission deadline for abstracts was Tuesday, Nov. 28. If you submitted an abstract, you will be sent a notification with the status of your submission via email by Dec. 15. If accepted, you will be directed to register for the course.
Contact firstname.lastname@example.org with questions.
An important part of the Advancing the Cardiovascular Care of the Oncology Patient experience remains the exhibits and industry sponsored reception. Both opportunities offer the chance for face-to-face networking with all attendees during dedicated times in the program. Learn more about the opportunities available in the Exhibitor Prospectus.
Clinical Topics: Cardio-Oncology